Literature DB >> 23015029

Do tumor grade and location affect survival in esophageal squamous cell carcinoma? Survival analysis of 302 cases of pT3N0M0 esophageal squamous cell carcinoma.

Dongrong Situ1, Weidong Wei, Peng Lin, Hao Long, Lanjun Zhang, Jianhua Fu, Tiehua Rong, Guowei Ma.   

Abstract

BACKGROUND: The 7th edition of the American Joint Committee on Cancer (AJCC) cancer staging manual incorporates tumor grade and location for staging pT2-3N0M0 esophageal squamous cell carcinoma. Patients with pT3N0M0, classified as stage IIa according to the 6th edition of the AJCC cancer staging manual, can now be classified as stage Ib, IIa, or IIb. We aimed to discuss whether these changes affect survival and determine other potential prognostic factors.
METHODS: We retrospectively analyzed 302 patients with postoperative pathologic stage T3N0M0 who underwent esophagectomy between 1990 and 2005 at Sun Yat-sen University Cancer Center. We performed univariate and multivariate analyses to identify prognostic factors for survival and used the Kaplan-Meier method to compare survival difference in each prognostic factor, including tumor grade and location.
RESULTS: The 5-year overall survival rate was 46 %, with a median survival of 1,244.5 days. Gender, age, alcohol consumption, forced expiratory volume in 1 s (FEV1), and number of removed lymph nodes were independent prognostic factors in both univariate and multivariate analyses. Smoking was also a prognostic factor in survival analysis by the Kaplan-Meier method. However, histologic tumor grade and location had no significant influence on patient survival.
CONCLUSIONS: Age, gender, alcohol consumption, FEV1, number of removed lymph nodes, and cigarette smoking are independent prognostic factors in patients with pT3N0M0 esophageal squamous cell carcinoma. However, tumor grade and location may not be as strong predictors in these patients as indicated in the 7th edition of the AJCC cancer staging manual.

Entities:  

Mesh:

Year:  2012        PMID: 23015029     DOI: 10.1245/s10434-012-2656-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  10 in total

Review 1.  Postoperative radiation therapy of pT2-3N0M0 esophageal carcinoma-a review.

Authors:  Yijun Luo; Xiaoli Wang; Jinming Yu; Bin Zhang; Minghuan Li
Journal:  Tumour Biol       Date:  2016-09-18

2.  Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.

Authors:  T W Rice; H Ishwaran; W L Hofstetter; D P Kelsen; C Apperson-Hansen; E H Blackstone
Journal:  Dis Esophagus       Date:  2016-11       Impact factor: 3.429

3.  The Application of Two-Stage Operation for High-Risk Patients with Oesophageal Cancer Following Gastrectomy.

Authors:  Gao-Li Liu; Xin Wang; Hai-Feng Hu; Zhi-Hao Nie; Wei Ming; Xing-Lin Long; Wen-Han Zhang; Xing-Hua Zhang; Jie Huang; Wan-Li Jiang; Song-Ping Xie
Journal:  J Gastrointest Surg       Date:  2022-08-01       Impact factor: 3.267

4.  Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma.

Authors:  Charles Lemarignier; Frédéric Di Fiore; Charline Marre; Sébastien Hapdey; Romain Modzelewski; Pierrick Gouel; Pierre Michel; Bernard Dubray; Pierre Vera
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-07-19       Impact factor: 9.236

5.  Is the new distribution of early esophageal adenocarcinoma stages improving the prognostic prediction of the 8th edition of the TNM staging system for esophageal cancer?

Authors:  Ran Mo; Chen Chen; Liang Pan; Ao Yu; Dongjin Wang; Tao Wang
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

6.  Prognostic Nomogram for Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy.

Authors:  Dan Su; Xinming Zhou; Qixun Chen; Youhua Jiang; Xun Yang; Weihui Zheng; Kaiyi Tao; Jie Wu; Zhen Yan; Liang Liu; Shaoyuan Wu; Weimin Mao
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

7.  Endoscopic Tumor Length Should Be Reincluded in the Esophageal Cancer Staging System: Analyses of 662 Consecutive Patients.

Authors:  Michele Valmasoni; Elisa Sefora Pierobon; Alberto Ruol; Carlo Alberto De Pasqual; Gianpietro Zanchettin; Lucia Moletta; Renato Salvador; Mario Costantini; Stefano Merigliano
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

8.  LYMPHOPARIETAL INDEX IN ESOPHAGEAL CANCER IS STRONGER THAN TNM STAGING IN LONG-TERM SURVIVAL PROGNOSIS IN A LATIN-AMERICAN COUNTRY.

Authors:  Manuel Figueroa-Giralt; Catalina Valenzuela; Andrés Torrealba; Attila Csendes; Italo Braghetto; Enrique Lanzarini; Maher Musleh; Owen Korn; Hector Valladares; Solange CortÉs
Journal:  Arq Bras Cir Dig       Date:  2021-01-15

9.  Right versus left transthoracic approach for lymph node-negative esophageal squamous cell carcinoma.

Authors:  Qilong Ma; Wengao Liu; Hao Long; Tiehua Rong; Lanjun Zhang; Yongbin Lin; Guowei Ma
Journal:  J Cardiothorac Surg       Date:  2015-09-18       Impact factor: 1.637

10.  The long-term impact of tumor burden in pT3N0M0 esophageal squamous cell carcinoma: A propensity score-matched analysis.

Authors:  Tingting Li; Xiaobin Fu; Lihua Xiao; Liyu Su; Yaqing Dai; Qiwei Yao; Jiancheng Li
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.